BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12070827)

  • 21. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris.
    Quindós G; Marcos-Arias C; San-Millán R; Mateo E; Eraso E
    Int Microbiol; 2018 Sep; 21(3):107-119. PubMed ID: 30810955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal susceptibilities of Candida species isolated from urine culture.
    Toka Özer T; Durmaz S; Yula E
    J Infect Chemother; 2016 Sep; 22(9):629-32. PubMed ID: 27452427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance of Candida species to antifungal agents used in the treatment of onychomycosis: a review of current problems.
    Evans EG
    Br J Dermatol; 1999 Nov; 141 Suppl 56():33-5. PubMed ID: 10730912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The changing pattern of Candida infections: different species and increased resistance].
    Kullberg BJ; Voss A
    Ned Tijdschr Geneeskd; 1996 Jan; 140(3):148-51. PubMed ID: 8618635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
    Krcméry V; Spánik S; Grausová S; Trupl J; Krupová I; Roidová A; Sálek T; Sufliarsky J; Mardiak J
    Neoplasma; 1998; 45(5):336-42. PubMed ID: 9921924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
    Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
    Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive Candida infections: the changing epidemiology.
    Marr KA
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):9-14. PubMed ID: 15682589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
    Wong-Beringera A; Hindler J; Brankovic L; Muehlbauer L; Steele-Moore L
    Diagn Microbiol Infect Dis; 2001 Jan; 39(1):25-31. PubMed ID: 11173188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool].
    Tashiro M; Murakami H; Yoshizawa S; Tateda K; Yamaguchi K
    Kansenshogaku Zasshi; 2012 Mar; 86(2 Suppl 4):15-20. PubMed ID: 23115940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal resistance: the clinical front.
    Perfect JR
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
    Fanci R
    J Chemother; 2009 Feb; 21(1):105-7. PubMed ID: 19297283
    [No Abstract]   [Full Text] [Related]  

  • 33. Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades.
    Safdar A; Perlin DS; Armstrong D
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):11-6. PubMed ID: 12376025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.
    Bailly S; Maubon D; Fournier P; Pelloux H; Schwebel C; Chapuis C; Foroni L; Cornet M; Timsit JF
    J Infect; 2016 Jan; 72(1):103-11. PubMed ID: 26518058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China.
    Sun H; Chen Y; Zou X; Li H; Yin X; Qin H; Liu R; Yu C; Li Q; Yu K; Han X; Zou J; Ge C; Han L
    Clin Oral Investig; 2016 Apr; 20(3):459-67. PubMed ID: 26220512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the distribution of colonising and infecting Candida spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: A 10-year study.
    Sasso M; Roger C; Sasso M; Poujol H; Barbar S; Lefrant JY; Lachaud L
    Mycoses; 2017 Dec; 60(12):770-780. PubMed ID: 28758337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.
    Pu S; Niu S; Zhang C; Xu X; Qin M; Huang S; Zhang L
    J Microbiol Immunol Infect; 2017 Feb; 50(1):97-103. PubMed ID: 25769664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
    Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
    Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.